A Randomized, Open-Label, Non-inferiority Clinical Trial Assessing 7 Versus 14 Days of Antimicrobial Therapy for Severe Multidrug-Resistant Gram-Negative Bacterial Infections: the OPTIMISE Trial Protocol

Beatriz Arns,Jaqueline Driemeyer C. Horvath,Gabriela Soares Rech,Guilhermo Prates Sesin,Crepin Aziz Jose Oluwafoumi Agani, Bruna Silveira da Rosa,Tiago Marcon dos Santos, Liliane Spencer Bittencourt Brochier,Alexandre Biasi Cavalcanti,Bruno Martins Tomazini,Adriano Jose Pereira,Viviane Cordeiro Veiga, Giovana Marssola Nascimento,Andre C. Kalil,Alexandre P. Zavascki

INFECTIOUS DISEASES AND THERAPY（2024）

Cited 2|Views17

Key words

Gram-negative bacilli,Antimicrobial therapy,Antimicrobial resistance,Enterobacterales,Klebsiella pneumoniae,Acinetobacter baumannii,Pseudomonas aeruginosa

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined